3-iodobenzylguanidine has been researched along with Diabetes Mellitus, Type 2 in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (30.00) | 18.2507 |
| 2000's | 17 (42.50) | 29.6817 |
| 2010's | 10 (25.00) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, K; Hoshika, Y; Ishikawa, M; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Ogano, M; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K | 1 |
| Attena, E; Boemio, A; Cuocolo, A; Femminella, GD; Formisano, R; Galasso, G; Leosco, D; Pagano, G; Paolillo, S; Pellegrino, T; Perrone-Filardi, P; Petraglia, L; Rengo, G; Savarese, G; Scopacasa, F; Trimarco, B; Tuccillo, M | 1 |
| Baumert, M; Sacre, JW | 1 |
| Armstrong, IS; Arumugam, P; Asghar, O; Malik, RA; Ray, SG; Schmitt, M | 1 |
| Martín, N; Muxí, À; Ortiz, JT; Taurà, P; Tejedor, A; Vendrell, M | 1 |
| Cappellini, C; Kusmic, C; L'abbate, A; Marini, C; Marzullo, P; Matteucci, M; Morbelli, S; Pomposelli, E; Sambuceti, G | 1 |
| Anan, F; Eshima, N; Masaki, T; Nakagawa, M; Saikawa, T; Takahashi, N; Yonemochi, H; Yoshimatsu, H | 3 |
| Anan, F; Eshima, N; Nakagawa, M; Saikawa, T; Takahashi, N; Takayuki, M; Yoshimatsu, H | 1 |
| Anan, F; Eshima, N; Masaki, T; Nakagawa, M; Saikawa, T; Shinohara, T; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Ghuman, N; Gjertson, CK; Kaur, M; Moskowitz, H; Tendler, B; White, WB | 1 |
| Bax, JJ; Bus, MT; Delgado, V; Dibbets-Schneider, P; Kharagitsingh, AV; Kok, JA; Maan, AC; Scholte, AJ; Schuijf, JD; Stokkel, MP; van der Wall, EE | 1 |
| Amanullah, A; Ananthasubramaniam, K; Caldwell, JH; Clements, IP; Gerson, MC; Henzlova, MJ; Jacobson, AF | 1 |
| Hage, FG; Iskandrian, AE | 1 |
| Hara, M; Nakagawa, M; Okada, N; Saikawa, T; Shinohara, T; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Baumert, M; Coombes, JS; Franjic, B; Marwick, TH; Sacre, JW | 1 |
| Rosenheck, S | 1 |
| Iida, Y; Kawashima, H; Kiyono, Y; Nishimura, H; Ogawa, M; Saji, H; Tamaki, N | 1 |
| Hara, M; Katsuragi, I; Nakagawa, M; Ooie, T; Saikawa, T; Sakino, H; Shigematsu, S; Takahashi, N; Tanaka, K; Watanabe, M; Yoshimatsu, H; Yufu, K | 1 |
| Anan, F; Hara, M; Nakagawa, M; Nawata, T; Ooie, T; Saikawa, T; Shigematsu, S; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Anan, F; Nakagawa, M; Ooie, T; Saikawa, T; Takahashi, N; Yoshimatsu, H | 1 |
| Hara, M; Nakagawa, M; Saikawa, T; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Anan, F; Eshima, N; Kakuma, T; Katsuragi, I; Masaki, T; Nakagawa, M; Saikawa, T; Shinohara, T; Takahashi, N; Tanaka, K; Yonemochi, H; Yoshimatsu, H | 1 |
| Anan, F; Goto, K; Hara, M; Kakuma, T; Katsuragi, I; Masaki, T; Nakagawa, M; Saikawa, T; Shinohara, T; Takahashi, N; Tanaka, K; Tsubone, T; Yoshimatsu, H; Yufu, K | 1 |
| Anan, F; Hara, M; Kakuma, T; Nakagawa, M; Saikawa, T; Shinohara, T; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Brunhölzl, C; Claus, D; Feistel, H; Neundörfer, B; Platsch, G; Wolf, F | 1 |
| Hoshizaki, H; Kamiyama, H; Kawazu, S; Naito, S; Nogami, A; Ohno, T; Ohshima, S; Okamoto, E; Taniguchi, K; Tomono, S; Toyama, T; Yuasa, K | 1 |
| Ahonen, A; Airaksinen, KE; Heikkila, J; Huikuri, HV; Koistinen, MJ; Linnaluoto, MM; Torniainen, P | 1 |
| Flores, LG; Futami, S; Hoshi, H; Jinnouchi, S; Matsukura, S; Nagamachi, S; Nakahara, H; Nakatsuru, K; Ohnishi, T; Toshimori, T; Watanabe, K | 1 |
| Kuikka, JT; Turpeinen, AK; Uusitupa, MI; Vanninen, E | 1 |
| Hattori, N; Hayashi, T; Konishi, J; Kudoh, T; Masuda, I; Nakao, K; Tadamura, E; Tamaki, N; Tateno, M; Yonekura, Y | 1 |
| Barr, A; Dorian, P; Freeman, MR; Langer, A; Newman, D | 1 |
| Endo, K; Iizuka, T; Inoue, T; Kato, N; Kubota, S; Nagai, R; Nagaoka, H; Suzuki, T | 1 |
| Kariyone, S; Nakatani, Y; Narabayashi, I; Onishi, S; Saika, Y; Tamura, K; Utsunomiya, K | 1 |
| Flores, LG; Futami, S; Jinnouchi, S; Kurose, T; Matsukura, S; Nagamachi, S; Nakahara, H; Ohnishi, T; Tamura, S | 1 |
| Togane, Y | 1 |
| Iwasaka, T; Nakatani, Y; Onishi, S; Saika, Y; Tamura, K; Utsunomiya, K | 1 |
| Hara, M; Katsuragi, I; Nakagawa, M; Okeda, T; Ooie, T; Saikawa, T; Sakata, T; Sakino, H; Shigematsu, S; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Futami, S; Jinnouchi, S; Kawai, K; Kurose, T; Matsukura, S; Nagamachi, S; Nishii, R; Tamura, S | 1 |
4 trial(s) available for 3-iodobenzylguanidine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
Topics: 3-Iodobenzylguanidine; Aged; Benzhydryl Compounds; Blood Pressure; Body Weight; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography, Ambulatory; Female; Glucosides; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Parasympathetic Nervous System; Radionuclide Imaging; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Sympathetic Nervous System; Uric Acid | 2020 |
Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: heart rate variation versus meta-iodo-benzylguanidine measured by single photon emission computed tomography.
Topics: 3-Iodobenzylguanidine; Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Heart; Heart Conduction System; Heart Rate; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Parasympathetic Nervous System; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 1994 |
Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart; Hemoglobin A; Humans; Hypertension; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 1999 |
Serial change in 123I-MIBG myocardial scintigraphy in non-insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Blood Glucose; Diabetes Mellitus, Type 2; Electrocardiography; Evaluation Studies as Topic; Female; Follow-Up Studies; Fructosamine; Heart; Humans; Male; Middle Aged; Myocardium; Neural Conduction; Radionuclide Ventriculography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tibial Nerve; Time Factors; Treatment Outcome | 2002 |
36 other study(ies) available for 3-iodobenzylguanidine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study.
Topics: 3-Iodobenzylguanidine; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2013 |
Heart rate complexity and cardiac sympathetic dysinnervation in patients with type 2 diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Heart; Heart Rate; Humans; Radionuclide Imaging; Supine Position; Sympathetic Nervous System | 2013 |
Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Heart; History, Ancient; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Young Adult | 2015 |
Magnesium sulphate and (123)I-MIBG in pheochromocytoma: Two useful techniques for a complicated disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Diabetes Mellitus, Type 2; Female; Humans; Magnesium Sulfate; Middle Aged; Pheochromocytoma | 2016 |
Whole-body evaluation of MIBG tissue extraction in a mouse model of long-lasting type II diabetes and its relationship with norepinephrine transport protein concentration.
Topics: 3-Iodobenzylguanidine; Animals; Biological Transport; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Kinetics; Liver; Male; Mice; Mice, Inbred C57BL; Myocardium; Norepinephrine; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Hepatocyte growth factor levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in patients with type 2 diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Aged; Asian People; Autonomic Nervous System Diseases; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart; Heart Diseases; Hepatocyte Growth Factor; Humans; Insulin Resistance; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Regression Analysis | 2009 |
Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Anthropometry; Autonomic Nervous System Diseases; Baroreflex; Body Composition; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Echocardiography; Female; Heart Rate; Humans; Hypertension; Insulin Resistance; Japan; Logistic Models; Male; Middle Aged; Norepinephrine; Radionuclide Imaging | 2009 |
White matter lesions are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetes mellitus patients.
Topics: 3-Iodobenzylguanidine; Aged; Baroreflex; Blood Glucose; Blood Pressure; Brain; Cardiovascular System; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Insulin; Logistic Models; Male; Middle Aged; Myocardial Perfusion Imaging; Norepinephrine; Pilot Projects; Radiopharmaceuticals | 2009 |
Radiating abdominal pain and hypertension.
Topics: 3-Iodobenzylguanidine; Abdominal Pain; Adrenal Gland Neoplasms; Aged, 80 and over; Antihypertensive Agents; Atenolol; Catecholamines; Diabetes Mellitus, Type 2; Female; Flank Pain; Humans; Hypertension; Magnetic Resonance Imaging; Pheochromocytoma; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diabetic Neuropathies; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Tomography, Emission-Computed, Single-Photon | 2010 |
Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients.
Topics: 3-Iodobenzylguanidine; Aged; Chi-Square Distribution; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2011 |
Cardiac autonomic denervation in diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Heart; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2011 |
Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
Topics: 3-Iodobenzylguanidine; Aged; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Failure; Humans; Iodine Radioisotopes; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Proportional Hazards Models; Radionuclide Imaging; Sensitivity and Specificity; Stroke | 2012 |
QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Arrhythmias, Cardiac; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electrocardiography; Female; Heart; Heart Rate; Humans; Iodine Radioisotopes; Linear Models; Male; Middle Aged; Patient Positioning; Predictive Value of Tests; Radiopharmaceuticals; Supine Position; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed, Single-Photon | 2013 |
Sympathetic dysinnervation, QT variability and the limitations of statistical work-up.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Heart; Humans; Iodine Radioisotopes; Male; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2013 |
Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Topics: 3-Iodobenzylguanidine; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Male; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Rats; Rats, Wistar; Reference Values; Symporters; Technetium Tc 99m Sestamibi; Tissue Distribution | 2002 |
Regulation of QT indices mediated by autonomic nervous function in patients with type 2 diabetes.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System; Baroreflex; Diabetes Mellitus, Type 2; Electrocardiography; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
Microalbuminuria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Aged; Aging; Albuminuria; Autonomic Nervous System Diseases; Baroreflex; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Echocardiography; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Insulin Resistance; Japan; Male; Middle Aged; Norepinephrine; Radiopharmaceuticals | 2004 |
High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System; Baroreflex; Body Constitution; Body Mass Index; C-Reactive Protein; Cardiovascular System; Diabetes Mellitus, Type 2; Echocardiography; Fasting; Female; Heart; Heart Rate; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Regression Analysis; Waist-Hip Ratio | 2005 |
Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System; Baroreflex; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart; Heart Conduction System; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Iodine Radioisotopes; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging | 2006 |
Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System; Baroreflex; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Echocardiography; Female; Glucose; Heart Rate; Humans; Hyperinsulinism; Insulin Resistance; Male; Middle Aged; Norepinephrine; Risk Factors; Smoking | 2006 |
Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Biomarkers; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2007 |
Abdominal visceral fat accumulation is associated with the results of (123)I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Adipose Tissue; Aged; Cardiovascular System; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Echocardiography; Female; Humans; Insulin Resistance; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Hypoadiponectinemia in type 2 diabetes mellitus in men is associated with sympathetic overactivity as evaluated by cardiac 123I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adiponectin; Aged; Baroreflex; Diabetes Mellitus, Type 2; Heart; Heart Rate; Humans; Insulin Resistance; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2007 |
Role of interleukin-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Baroreflex; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Electrocardiography; Female; Heart Rate; Humans; Interleukin-6; Male; Middle Aged; Norepinephrine; Radionuclide Imaging | 2008 |
Evaluation of cardiac sympathetic nervous function by 123I-metaiodobenzylguanidine scintigraphy in insulin-treated non-insulin dependent diabetics with hypoglycemia unawareness.
Topics: 3-Iodobenzylguanidine; Diabetes Mellitus, Type 2; Epinephrine; Heart; Heart Function Tests; Humans; Hypoglycemia; Hypoglycemic Agents; Injections, Intravenous; Insulin; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Norepinephrine; Perception; Radionuclide Imaging; Sympathetic Nervous System; Sympatholytics | 1996 |
No difference in cardiac innervation of diabetic patients with painful and asymptomatic coronary artery disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Coronary Disease; Denervation; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electroencephalography; Exercise Test; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Pain; Radiography; Radionuclide Imaging | 1996 |
123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon | 1996 |
Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System; Blood Pressure; Contrast Media; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Echocardiography; Epinephrine; Female; Heart; Heart Rate; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Muscle Denervation; Norepinephrine; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Regional abnormality of iodine-123-MIBG in diabetic hearts.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System Diseases; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon | 1996 |
Relation of direct assessment of cardiac autonomic function with metaiodobenzylguanidine imaging to heart rate variability in diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System; Contrast Media; Diabetes Mellitus, Type 2; Heart; Heart Rate; Humans; Iodine Radioisotopes; Iodobenzenes | 1997 |
Depressed contractile response to exercise in diabetic patients in the absence of cardiovascular disease: relationship to adrenergic cardiac dysinnervation.
Topics: 3-Iodobenzylguanidine; Biological Transport; Diabetes Mellitus, Type 2; Exercise Test; Female; Humans; Japan; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Radionuclide Angiography; Radiopharmaceuticals; Reference Values; Sympatholytics; Thallium Radioisotopes; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
Effects of aldose reductase inhibitor and vitamin B12 on myocardial uptake of iodine-123 metaiodobenzylguanidine in patients with non-insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Aldehyde Reductase; Autonomic Nervous System Diseases; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Enzyme Inhibitors; Female; Heart; Heart Diseases; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rhodanine; Thiazolidines; Vitamin B 12 | 1998 |
123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System Diseases; Cardiomyopathies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Heart; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1998 |
Evaluation of the cardiac autonomic nervous system in spontaneously non-insulin-dependent diabetic rats by 123I-metaiodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Epinephrine; Heart; Insulin; Iodine Radioisotopes; Male; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred OLETF | 1999 |
Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System; Baroreflex; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart; Heart Function Tests; Heart Rate; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Norepinephrine; Radiopharmaceuticals | 2001 |